UY31171A1 - Anhídridos y polímeros de esteres borónicos cíclicos y acíclicos, sus enantiómeros, sus sales farmacéuticamente aceptables, composiciones conteniéndolos y aplicaciones. - Google Patents
Anhídridos y polímeros de esteres borónicos cíclicos y acíclicos, sus enantiómeros, sus sales farmacéuticamente aceptables, composiciones conteniéndolos y aplicaciones.Info
- Publication number
- UY31171A1 UY31171A1 UY31171A UY31171A UY31171A1 UY 31171 A1 UY31171 A1 UY 31171A1 UY 31171 A UY31171 A UY 31171A UY 31171 A UY31171 A UY 31171A UY 31171 A1 UY31171 A1 UY 31171A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions containing
- enantiomers
- cyclic
- polymers
- applications
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title 1
- -1 ESTERS ANHYDRIDES Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94529407P | 2007-06-20 | 2007-06-20 | |
US4117808P | 2008-03-31 | 2008-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31171A1 true UY31171A1 (es) | 2009-04-30 |
Family
ID=40156702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31171A UY31171A1 (es) | 2007-06-20 | 2008-06-20 | Anhídridos y polímeros de esteres borónicos cíclicos y acíclicos, sus enantiómeros, sus sales farmacéuticamente aceptables, composiciones conteniéndolos y aplicaciones. |
Country Status (29)
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5038912B2 (ja) | 2005-02-16 | 2012-10-03 | アナコール ファーマシューティカルズ,インコーポレイテッド | ホウ素含有小分子 |
RU2008131324A (ru) | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
EP1988779B1 (en) | 2006-02-16 | 2015-06-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
JP2009536660A (ja) | 2006-05-02 | 2009-10-15 | アナコール ファーマシューティカルズ,インコーポレイテッド | 加水分解耐性ホウ素含有治療剤及びその使用方法 |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
KR20150065941A (ko) | 2008-03-06 | 2015-06-15 | 아나코르 파마슈티칼스 인코포레이티드 | 소염제로써 붕소가 함유된 소분자 |
EP2285384A4 (en) * | 2008-05-12 | 2012-04-25 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
EP2348863A4 (en) | 2008-09-04 | 2012-03-07 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
US8461336B2 (en) | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
US8461364B2 (en) * | 2008-12-17 | 2013-06-11 | Glaxosmithkline Llc | Polymorphs of (S)-3-aminomethyl-7-(3-hydroxy-propoxy)-3H-benzo[C][1,2]oxaborol-1-OL |
US8668911B2 (en) * | 2009-05-14 | 2014-03-11 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
RU2012107163A (ru) | 2009-07-28 | 2013-09-10 | Анакор Фармасьютикалз, Инк. | Тризамещенные борсодержащие молекулы |
WO2011019616A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
WO2011019612A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US9440994B2 (en) | 2009-08-14 | 2016-09-13 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
US20110207701A1 (en) * | 2009-08-19 | 2011-08-25 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US20110124597A1 (en) * | 2009-09-25 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules |
US8979820B2 (en) | 2009-10-09 | 2015-03-17 | Cynthia S. Bailey | Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes |
US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
WO2011060196A1 (en) * | 2009-11-11 | 2011-05-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8716478B2 (en) | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8623911B2 (en) | 2010-03-19 | 2014-01-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
CA2794684C (en) * | 2010-04-07 | 2018-04-24 | Glaxosmithkline Llc | Process for preparing benzoxaboroles |
EA033311B1 (ru) * | 2010-09-07 | 2019-09-30 | Анакор Фармасьютикалс, Инк. | Производные бензоксаборола в качестве антибактериальных средств |
WO2013025975A1 (en) * | 2011-08-17 | 2013-02-21 | Glaxosmithkline Llc | Combination treatments for hepatitis c |
US9162999B2 (en) | 2011-09-28 | 2015-10-20 | Wisconsin Alumni Research Foundation | Catalytic conversion of cellulose to fuels and chemicals using boronic acids |
AR088668A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
AR088669A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
EP2793901A1 (en) | 2011-12-22 | 2014-10-29 | Micurx Pharmaceuticals, Inc. | Tricyclic boron compounds for antimicrobial therapy |
WO2013154759A1 (en) * | 2012-04-14 | 2013-10-17 | Anacor Pharmaceuticals, Inc. | Benzoxaborole compounds and uses thereof |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
NZ710723A (en) | 2013-01-30 | 2019-12-20 | Agrofresh Inc | Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
AP2015008638A0 (en) | 2013-02-01 | 2015-08-31 | Anacor Pharmaceuticals Inc | Boron-containing small molecules as antiprotozoal agents |
AU2014202928B1 (en) * | 2013-06-05 | 2014-09-11 | Agrofresh Inc. | Compounds and compositions |
KR101636431B1 (ko) * | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
PE20160752A1 (es) | 2013-08-09 | 2016-08-17 | Anacor Pharmaceuticals Inc | Compuestos de benzoxaborol triciclicos y usos de los mismos |
EA038093B1 (ru) * | 2013-12-20 | 2021-07-05 | Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед | Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли |
RU2016137000A (ru) * | 2014-02-17 | 2018-03-22 | Зингента Партисипейшнс Аг | Микробиоцидно активные бензоксаборолы |
TW201625649A (zh) * | 2014-07-01 | 2016-07-16 | 第一三共股份有限公司 | 作爲抗菌劑的三環化合物 |
US9738664B2 (en) * | 2014-10-29 | 2017-08-22 | Wisconsin Alumni Research Foundation | Boronic acid inhibitors of HIV protease |
MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
CN107872956B (zh) | 2015-04-09 | 2020-07-10 | 宾夕法尼亚州研究基金会 | 含有苯并氧杂硼戊环的协同性抗真菌组合物 |
WO2017024022A1 (en) * | 2015-08-06 | 2017-02-09 | The Penn State Research Foundation | Benzoxaborole-containing coating resistant to cellulose-supportable fungus |
EP3423159A4 (en) | 2016-03-02 | 2019-11-06 | Anacor Pharmaceuticals, Inc. | BORN SMALL MOLECULES |
US10874679B2 (en) | 2016-03-02 | 2020-12-29 | Bill & Melinda Gates Foundation | Boron-containing small molecules |
US10611780B2 (en) | 2016-03-02 | 2020-04-07 | Bill And Melinda Gates Foundation | Boron-containing small molecules |
NZ745681A (en) | 2016-03-07 | 2022-05-27 | Agrofresh Inc | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
AU2017263785B2 (en) | 2016-05-12 | 2019-10-03 | Anacor Pharmaceuticals, Inc. | Oxaborole esters and uses thereof |
MA52337A (fr) | 2017-03-01 | 2021-03-03 | Anacor Pharmaceuticals Inc | Nouveaux analogues d'oxaborole et utilisations de ces derniers |
CN107090000B (zh) * | 2017-04-27 | 2019-07-12 | 上海交通大学 | 一种苯并硼唑7位脂肪酸的衍生物及其制备与用途 |
EP4265332A3 (en) * | 2017-06-13 | 2024-01-10 | Veterinary Diagnostics Institute, Inc. | System and procedure for stabilizing, storing and recovering blood samples |
AU2018375795A1 (en) | 2017-11-30 | 2020-07-02 | Boragen, Inc. | Benzoxaborole compounds and formulations thereof |
CA3120974A1 (en) * | 2017-11-30 | 2019-06-06 | Boragen, Inc. | Combinatorial compositions of benzoxaboroles and biologic agents |
CA3148168A1 (en) * | 2018-08-18 | 2020-02-27 | Chun Yu Liu | Solid forms of substituted benzoxaborole and compositions thereof |
WO2020051575A1 (en) * | 2018-09-07 | 2020-03-12 | Boragen, Inc. | Boron containing compounds and their uses |
US11058695B2 (en) * | 2019-11-08 | 2021-07-13 | Myongji University Industry And Academia Cooperation Foundation | Inhibitor of carbapenem-hydrolyzing class D beta-lactamases |
EP4204012A1 (en) | 2020-08-31 | 2023-07-05 | Pfizer Inc. | Methods of protecting rna |
EP4384185A1 (en) * | 2022-06-23 | 2024-06-19 | Micurx Pharmaceuticals, Inc. | Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same |
EP4384527A1 (en) * | 2022-06-23 | 2024-06-19 | Micurx Pharmaceuticals, Inc. | Prodrugs of boron compounds and their use in treating bacterial infections |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2260336A (en) * | 1939-10-16 | 1941-10-28 | Dow Chemical Co | Method of preparation of organic borates |
GB1396904A (en) * | 1972-08-11 | 1975-06-11 | Ici Ltd | Method for the control of micro-organisms |
US5962498A (en) * | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
US5594151A (en) * | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
GB9411587D0 (en) * | 1994-06-09 | 1994-08-03 | Zeneca Ltd | Compound, composition and use |
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
US5831046A (en) * | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
US6306628B1 (en) * | 1999-08-25 | 2001-10-23 | Ambergen, Incorporated | Methods for the detection, analysis and isolation of Nascent proteins |
US6369098B1 (en) * | 1999-10-05 | 2002-04-09 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
JP2004506417A (ja) * | 2000-07-14 | 2004-03-04 | ザイコス インク. | α−MSH関連化合物および使用方法 |
US6537733B2 (en) * | 2001-02-23 | 2003-03-25 | Applied Materials, Inc. | Method of depositing low dielectric constant silicon carbide layers |
GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
DE10143979A1 (de) | 2001-09-07 | 2003-03-27 | Clariant Gmbh | Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren |
JPWO2003033002A1 (ja) * | 2001-10-11 | 2005-02-03 | 御子柴 克彦 | 細胞内カルシウム濃度上昇抑制剤 |
CN1325504C (zh) | 2002-01-10 | 2007-07-11 | 宾夕法尼亚州研究基金会 | 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法 |
JP2005538953A (ja) * | 2002-05-28 | 2005-12-22 | 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド | 新規チオフェンアミジン、それらの組成物、および補体媒介疾患および病気を治療する方法 |
AU2004262524C1 (en) * | 2003-06-16 | 2010-08-19 | Anacor Pharmaceuticals, Inc. | Hydrolytically-resistant boron-containing therapeutics and methods of use |
CA2607686C (en) * | 2004-05-12 | 2014-11-04 | Thomas P. Stossel | Use of gelsolin to treat infections |
JP5038912B2 (ja) | 2005-02-16 | 2012-10-03 | アナコール ファーマシューティカルズ,インコーポレイテッド | ホウ素含有小分子 |
RU2008131324A (ru) * | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
EP1988779B1 (en) * | 2006-02-16 | 2015-06-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
MX2008015918A (es) | 2006-06-12 | 2009-01-14 | Anacor Pharmaceuticals Inc | Compuestos para el tratamiento de enfermedad periodontal. |
US20070286822A1 (en) * | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
DE102006038471A1 (de) | 2006-08-17 | 2008-04-10 | Wala-Heilmittel Gmbh | Platanencreme, Verfahren zu ihrer Herstellung und Verwendung |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
EP2285384A4 (en) * | 2008-05-12 | 2012-04-25 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
-
2008
- 2008-06-18 JO JOP/2008/0288A patent/JO3396B1/ar active
- 2008-06-19 JP JP2010513416A patent/JP5530923B2/ja active Active
- 2008-06-19 MX MX2015007480A patent/MX347688B/es unknown
- 2008-06-19 CN CN200880101464.4A patent/CN101772302B/zh active Active
- 2008-06-19 MY MYPI20095460A patent/MY162692A/en unknown
- 2008-06-19 EA EA200901617A patent/EA020530B1/ru not_active IP Right Cessation
- 2008-06-19 CA CA2692135A patent/CA2692135C/en active Active
- 2008-06-19 NZ NZ582706A patent/NZ582706A/en unknown
- 2008-06-19 US US12/142,692 patent/US7816344B2/en active Active
- 2008-06-19 BR BRPI0813450A patent/BRPI0813450B8/pt active IP Right Grant
- 2008-06-19 CN CN201410134063.6A patent/CN104017008A/zh active Pending
- 2008-06-19 ES ES08825921.3T patent/ES2655299T3/es active Active
- 2008-06-19 DK DK08825921.3T patent/DK2164331T3/da active
- 2008-06-19 EP EP08825921.3A patent/EP2164331B1/en active Active
- 2008-06-19 KR KR1020167009966A patent/KR101685656B1/ko active IP Right Grant
- 2008-06-19 KR KR1020157021997A patent/KR20150100945A/ko not_active IP Right Cessation
- 2008-06-19 SG SG2012045712A patent/SG182219A1/en unknown
- 2008-06-19 AU AU2008265630A patent/AU2008265630B2/en active Active
- 2008-06-19 KR KR1020107001062A patent/KR101578351B1/ko active IP Right Grant
- 2008-06-19 WO PCT/US2008/067550 patent/WO2008157726A1/en active Application Filing
- 2008-06-19 NO NO08825921A patent/NO2164331T3/no unknown
- 2008-06-20 CL CL2008001855A patent/CL2008001855A1/es unknown
- 2008-06-20 AR ARP080102661A patent/AR067105A1/es active IP Right Grant
- 2008-06-20 UY UY31171A patent/UY31171A1/es unknown
- 2008-06-20 PE PE2008001074A patent/PE20090840A1/es not_active Application Discontinuation
- 2008-06-20 TW TW097123257A patent/TW200911822A/zh unknown
-
2009
- 2009-11-26 IL IL202379A patent/IL202379A/en active IP Right Grant
- 2009-12-11 DO DO2009000281A patent/DOP2009000281A/es unknown
- 2009-12-17 ZA ZA2009/09003A patent/ZA200909003B/en unknown
- 2009-12-18 CO CO09145296A patent/CO6251209A2/es not_active Application Discontinuation
-
2010
- 2010-01-15 MA MA32517A patent/MA31675B1/fr unknown
- 2010-01-18 CR CR11224A patent/CR11224A/es unknown
- 2010-07-30 US US12/848,051 patent/US8895534B2/en active Active
-
2011
- 2011-06-21 ZA ZA2011/04573A patent/ZA201104573B/en unknown
-
2014
- 2014-04-21 JP JP2014087397A patent/JP2014148531A/ja active Pending
- 2014-11-07 US US14/536,483 patent/US9796735B2/en active Active
-
2015
- 2015-09-24 JP JP2015187239A patent/JP6570391B2/ja active Active
-
2017
- 2017-09-28 US US15/718,422 patent/US10533021B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31171A1 (es) | Anhídridos y polímeros de esteres borónicos cíclicos y acíclicos, sus enantiómeros, sus sales farmacéuticamente aceptables, composiciones conteniéndolos y aplicaciones. | |
CL2009000650A1 (es) | Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras | |
CL2010001637A1 (es) | Compuestos derivados de isoindolonas; composición farmacéutica que los comprende; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas y/o inflamatorias tales como cáncer, artritis reumatoidea entre otras. | |
CL2011000691A1 (es) | Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias. | |
CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
CL2017002482A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
ECSP099445A (es) | Quinazolinas para la inhibición de pdk1 | |
CL2010001641A1 (es) | Compuestos derivados de heterociclos biciclicos sustituidos; composicion farmaceutica; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas e inflamatorias tales como cancer y artritis reumatoide entre otras. | |
CL2011003147A1 (es) | Compuestos derivados de n-(1-4-(1h-pirazol-5-il)ftalazina-1-il) piperidina-4-il) benzamida; composicion farmaceutica que los contiene, utiles como antagonista de la trayectoria de hedgehog, en el tratamiento del cancer. | |
CL2011000668A1 (es) | Compuestos derivados de pirazolopiridina; proceso de preparacion; composicion farmaceutica y uso en el tratamiento de enfermedades tales como artritis reumatoide, psoriasis, esclerosis multiple, entre otras. | |
GT200800184A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
MX2012002031A (es) | Moleculas pequeñas que contienen boro como agentes antiprotozoarios. | |
UY31860A (es) | Piridinas de tiazolo como inhibidoras de la adn girasa | |
CL2008000202A1 (es) | Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor. | |
CL2011001427A1 (es) | Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras. | |
UY32937A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
CO6430428A2 (es) | Composiciones, síntesis, y métodos de utilización de derivados de arilopiperazina | |
HN2010001647A (es) | INHIBIDORES DE HETEROCICLICOS DE ESTEAROIL-CoA-DESATURASA | |
CL2012001031A1 (es) | Compuestos derivados de 2-oxo-1-pirrolidinil-imidazotiadiazol; composición farmacéutica que los comprende; útiles para el tratamiento de la epilepsia, transtornos neurológicos, entre otros. | |
BR112019024566A2 (pt) | inibidores de pirazol magl | |
CL2011000258A1 (es) | Compuestos derivados de fenilamino-isonicotinamida; inhibidores de mek; composicion farmaceutica y uso para el tratamiento de enfermedades hiperproliferativas tales como cancer e inflamacion. | |
CL2017002451A1 (es) | Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2017002803A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2011002907A1 (es) | Compuestos derivados de nitrilo; sus composiciones farmacéuticas y su uso para el tratamiento de enfermedades hiperproliferativas. | |
AR072425A1 (es) | Uso de nifurtimox para el tratamiento de giardiasis |